Stereotaxis (NYSE: STXS) announced a definitive agreement to acquire Robocath, a French developer of robotic technologies for interventional cardiology and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE